ClinicalTrials.Veeva

Menu

Novel mHealth Physical Activity Intervention for Youth With Type 1 Diabetes Mellitus

Children's Mercy Hospital Kansas City logo

Children's Mercy Hospital Kansas City

Status

Begins enrollment in 8 months

Conditions

Type 1 Diabetes

Treatments

Other: NUDGE

Study type

Observational

Funder types

Other

Identifiers

NCT06018844
STUDY00002143

Details and patient eligibility

About

The goal of this longitudinal cohort study is to learn about a mHealth intervention in Type 1 Diabetes (T1D)

The main question[s] it aims to answer are:

  • Does the intervention increase the amount of text messages between the mHealth software and participants?
  • Do the text messages from the Nudge software increase moderate to vigorous physical activity (MVPA) in participants?
  • Does the MVPA encouraged by the Nudge software improve the HbA1c levels of participants?

Participants will:

  • Receive text messages from the Nudge software
  • Report physical activity goals via the text messages to the Nudge software
  • Wear both an accelerometer and an actigraph for three weeks (spread out across the beginning, 30 days, and 90 days of participation)
  • Complete surveys at the beginning of participation
  • Complete daily surveys while wearing the devices
  • Complete surveys at the end of participation
  • Record physical activity in study surveys

Enrollment

250 estimated patients

Sex

All

Ages

13 to 21 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Participants 12.00-21.99 years old
  • Participants with a physician confirmed T1D diagnosis.
  • T1D diagnosis was at least 6 months prior to study enrollment
  • Participants are on an intensive insulin regiment (either with an insulin pump or multiple daily injection)
  • Participants must be using a continuous glucose monitor (CGM)
  • Participants and parents/legally authorized representatives (LARS) of participants less than 18.00 speak/read English.

Exclusion criteria

  • Participants with evidence of type 2 or monogenic diabetes.
  • Participants with a comorbid chronic condition (e.g., renal disease).
  • Participants with presence of severe psychiatric disorders.
  • Participants with a diagnosis of low vision (vision that cannot be corrected with contact lenses or eyeglasses).
  • Participants with limited mobility that would prevent participant from engaging in daily physical activity, self-assessed by participant.

Trial contacts and locations

0

Loading...

Central trial contact

Claire Petty; Priscilla Connell, MPH

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems